K M Pisters

Summary

Affiliation: The University of Texas M. D. Anderson Cancer Center
Country: USA

Publications

  1. ncbi request reprint Phase I trial of oral green tea extract in adult patients with solid tumors
    K M Pisters
    Department of Thoracic Head and Neck Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 19:1830-8. 2001
  2. ncbi request reprint ZD1839 (Iressa) in non-small-cell lung cancer
    R S Herbst
    Department of Thoracic Head and Neck Medical Oncology, UT M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Lung Cancer 3:27-32. 2001
  3. ncbi request reprint Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma
    B S Glisson
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 17:2309-15. 1999

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Phase I trial of oral green tea extract in adult patients with solid tumors
    K M Pisters
    Department of Thoracic Head and Neck Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 19:1830-8. 2001
    ..This trial was designed to determine the maximum-tolerated dose, toxicity, and pharmacology of oral green tea extract (GTE) once daily or three times daily...
  2. ncbi request reprint ZD1839 (Iressa) in non-small-cell lung cancer
    R S Herbst
    Department of Thoracic Head and Neck Medical Oncology, UT M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Lung Cancer 3:27-32. 2001
    ..ZD1839 is currently in phase III clinical development for the treatment of advanced NSCLC...
  3. ncbi request reprint Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma
    B S Glisson
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 17:2309-15. 1999
    ....